SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,616.51 |
| Enterprise Value ($M) | 1,334.55 |
| Book Value ($M) | 733.54 |
| Book Value / Share | 7.54 |
| Price / Book | 2.20 |
| NCAV ($M) | 507.87 |
| NCAV / Share | 5.22 |
| Price / NCAV | 3.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.82 |
| Current Ratio | 4.82 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 878.15 |
| Assets | 1,103.82 |
| Liabilities | 370.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 63.52 |
| Operating Income | -415.57 |
| Net Income | -376.74 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -347.25 |
| Cash from Investing | 185.01 |
| Cash from Financing | 7.74 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 7.50 | -3.21 | |
| 13G/A | Fmr Llc | 10.10 | 84.62 | |
| 13G/A | ARCH Venture Fund IX, L.P. | 5.60 | -16.41 | |
| 13G/A | Farallon Capital Partners, L.P. | 9.90 | 0.38 | |
| 13G/A | ARK Investment Management LLC | 7.92 | -30.48 | |
| 13G/A | State Street Corp | 4.80 | -14.88 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 256,627 | 916,406 | 28.00 | |
| 387,246 | 1,446,328 | 26.77 | |
| 396,892 | 1,656,356 | 23.96 | |
| 616,141 | 2,654,838 | 23.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BBIO – BridgeBio Pharma, Inc. | BCRX – BioCryst Pharmaceuticals, Inc. |
| BDTX – Black Diamond Therapeutics, Inc. | BIIB – Biogen Inc. |
| BLUE – bluebird bio, Inc. |
Financial data and stock pages provided by
Fintel.io